Yeasts in nanotechnology-enabled oral vaccine and gene delivery

Oral vaccine and gene delivery systems must be engineered to withstand several different physiological environments, such as those present in the oral cavity, stomach, and jejunum, each of which exhibits varying pH levels and enzyme distributions. Additionally, these systems must be designed to ensu...

Full description

Saved in:
Bibliographic Details
Main Author: Elena Ivanova
Format: article
Language:EN
Published: Taylor & Francis Group 2021
Subjects:
Online Access:https://doaj.org/article/90a7907618604ef0acfc7994ba7c83a4
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:doaj.org-article:90a7907618604ef0acfc7994ba7c83a4
record_format dspace
spelling oai:doaj.org-article:90a7907618604ef0acfc7994ba7c83a42021-11-04T15:51:53ZYeasts in nanotechnology-enabled oral vaccine and gene delivery2165-59792165-598710.1080/21655979.2021.1985816https://doaj.org/article/90a7907618604ef0acfc7994ba7c83a42021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.1985816https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987Oral vaccine and gene delivery systems must be engineered to withstand several different physiological environments, such as those present in the oral cavity, stomach, and jejunum, each of which exhibits varying pH levels and enzyme distributions. Additionally, these systems must be designed to ensure appropriate gastrointestinal absorption and tissue/cellular targeting properties. Yeasts-based delivery vehicles are excellent candidates for oral vaccine and oral gene therapies as many species possess cellular characteristics resulting in enhanced resistance to the harsh gastrointestinal (GI) environment and facilitated passage across the mucosal barrier. Yeast capsules can stimulate and modulate host immune responses, which is beneficial for vaccine efficacy. In addition, recombinant modification of yeasts to express cell penetrating proteins and injection mechanisms along with efficient cell adhering capabilities can potentially improve transfection rates of genetic material. In this literature review, we present evidence supporting the beneficial role yeast-based delivery systems can play in increasing the efficacy of oral administration of vaccines and gene therapies.Elena IvanovaTaylor & Francis Grouparticleoral vaccinessynthetic yeastgene deliverynanoparticlesBiotechnologyTP248.13-248.65ENBioengineered, Vol 12, Iss 1, Pp 8325-8335 (2021)
institution DOAJ
collection DOAJ
language EN
topic oral vaccines
synthetic yeast
gene delivery
nanoparticles
Biotechnology
TP248.13-248.65
spellingShingle oral vaccines
synthetic yeast
gene delivery
nanoparticles
Biotechnology
TP248.13-248.65
Elena Ivanova
Yeasts in nanotechnology-enabled oral vaccine and gene delivery
description Oral vaccine and gene delivery systems must be engineered to withstand several different physiological environments, such as those present in the oral cavity, stomach, and jejunum, each of which exhibits varying pH levels and enzyme distributions. Additionally, these systems must be designed to ensure appropriate gastrointestinal absorption and tissue/cellular targeting properties. Yeasts-based delivery vehicles are excellent candidates for oral vaccine and oral gene therapies as many species possess cellular characteristics resulting in enhanced resistance to the harsh gastrointestinal (GI) environment and facilitated passage across the mucosal barrier. Yeast capsules can stimulate and modulate host immune responses, which is beneficial for vaccine efficacy. In addition, recombinant modification of yeasts to express cell penetrating proteins and injection mechanisms along with efficient cell adhering capabilities can potentially improve transfection rates of genetic material. In this literature review, we present evidence supporting the beneficial role yeast-based delivery systems can play in increasing the efficacy of oral administration of vaccines and gene therapies.
format article
author Elena Ivanova
author_facet Elena Ivanova
author_sort Elena Ivanova
title Yeasts in nanotechnology-enabled oral vaccine and gene delivery
title_short Yeasts in nanotechnology-enabled oral vaccine and gene delivery
title_full Yeasts in nanotechnology-enabled oral vaccine and gene delivery
title_fullStr Yeasts in nanotechnology-enabled oral vaccine and gene delivery
title_full_unstemmed Yeasts in nanotechnology-enabled oral vaccine and gene delivery
title_sort yeasts in nanotechnology-enabled oral vaccine and gene delivery
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/90a7907618604ef0acfc7994ba7c83a4
work_keys_str_mv AT elenaivanova yeastsinnanotechnologyenabledoralvaccineandgenedelivery
_version_ 1718444727767924736